Discussed in this episode:
- The FDA’s just approved a new round of COVID shots, tuned to target the KP.2 subvariant of the the virus, which is not the dominant strain in circulation right now, but a close relative. MRNA vaccines from Pfizer and Moderna should be available as soon as this week.
- The updated Novavax vaccine, which will target the older JN.1 subvariant, is still awaiting approval.
To send us a question in advance of next week’s show, write to: [email protected]. Tune in live Monday mornings at 7:30am Pacific at kpfa.org
Podcast music credit: Now Son by Podington Bear, licensed under a Attribution-NonCommercial 3.0 International License.